Carnegie Mellon University-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2023

  1. Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients

    Cancers, Vol. 15, Núm. 7

  2. Multi-site, multi-country randomized clinical trial of an acute traumatic brain injury caregiver transition assistance program in Latin America

    NeuroRehabilitation, Vol. 52, Núm. 1, pp. 137-147

  3. Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression

    Scientific Reports, Vol. 13, Núm. 1

  4. The Neurogenetics of Functional Connectivity Alterations in Autism: Insights From Subtyping in 657 Individuals

    Biological Psychiatry, Vol. 94, Núm. 10, pp. 804-813

2021

  1. The effect of 5-HT1A receptor agonists on the entopeduncular nucleus is modified in 6-hydroxydopamine-lesioned rats

    British Journal of Pharmacology, Vol. 178, Núm. 12, pp. 2516-2532

2020

  1. RKIP regulates differentiation-related features in melanocytic cells

    Cancers, Vol. 12, Núm. 6, pp. 1-22

  2. Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study

    Molecular Oncology, Vol. 14, Núm. 8, pp. 1705-1718

2017

  1. Treat-To-Target (T2T) recommendations for gout

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 4, pp. 632-638

2014

  1. A unified nomenclature and amino acid numbering for human PTEN

    Science Signaling, Vol. 7, Núm. 332

2012

  1. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  2. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196